AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2014
Jul 9, 2014
34501_dirs_2014-07-09_faa627a8-bc4d-4ab0-b0b6-d47490ee1cc0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-07-07
Reporting Person: Kraus Al (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-07 | Common Stock | M | 50000 | $0.035 | Acquired | 1443631 | Direct |
| 2014-07-07 | Common Stock | S | 50000 | $0.235 | Disposed | 1393631 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-07 | Stock Option | $0.035 | M | 50000 | Disposed | 2018-06-25 | Common Stock (50000) | Direct |
Footnotes
F1: Stock option exercise and open market sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 30
Regulatory Filings
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Regulatory Filings
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Regulatory Filings
2025
Oct 3
Regulatory Filings
2025
Sep 16